Skip to main content

Table 1 Clinical characteristics of patients

From: Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast

Variable

Number of patients

%

All patients

123

100

Age (years)

  

   ≤45

49

40

   >45

74

60

ER status

  

   Positive

75

61

   Negative

48

39

PR status

  

   Positive

74

60

   Negative

49

40

HER2 status

  

   Positive

41

33

   Negative

82

67

T stage

  

   1

60

49

   2

49

40

   3

10

8

   4

4

3

N stage

  

   0

63

51

   1

29

24

   2

18

15

   3

13

11

M stage

  

   0

114

93

   1

9

7

Chemotherapy

  

   No

19

15

   Yes

104

85

Hormone receptor targeting therapy

 

   No

34

28

   Yes

89

72

Radiation therapy

  

   No

50

41

   Yes

73

59

Herceptin

  

   No

102

83

   Yes

21

17

  1. ER = Estrogen receptor, PR = Progesterone receptor, HER2 = Human epidermal growth factor receptor 2.